- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06608446
Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery (LINFO)
Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery: Randomized Controlled Trial
The most common complaints after breast surgery are postoperative pain reported in up to 68% of patients, musculoskeletal problems in the shoulder and functional limitations in up to 59% of patients after mastectomy and quadrantectomy, reduction in range of motion ( ROM) in 24-53% and strength deficit.
The study aims to verify the effectiveness of a telerehabilitation treatment in terms of prevention of possible complications following breast cancer surgery.
Primary objective: to examine whether the group of patients undergoing rehabilitation surgery in the immediate post-operative period shows a reduction in the onset of complications compared to the group of patients who followed standard procedures.
Secondary objective: to study any preoperative prognostic factors for the onset of complications, to study the effectiveness of the rehabilitation treatment in terms of reduction of painful symptoms, improvement of joint ROM, muscle strength and perceived quality of life.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Breast cancer is the most common malignancy in women worldwide. Advances in early detection and improved treatment of breast cancer have led to increased survival after diagnosis, resulting in many more women living with the consequences of cancer treatment.
Breast cancer surgeries and treatments can cause arm morbidity that can progress beyond 2.5 years.
The most common complaints after breast surgery are postoperative pain reported in up to 68% of patients, musculoskeletal problems in the shoulder and functional limitations in up to 59% of patients after mastectomy and quadrantectomy, reduction in range of motion ( ROM) in 24-53% and strength deficit.
Other complications include postoperative axillary web syndrome (AWS), which can cause pain and movement limitations; lymphedema reported with a prevalence of 6-52% especially after axillary lymph node dissection (ALND); kinematic alterations that may promote future development of rotator cuff disease; scapulohumeral dyskinesia, proprioception deficit, postural alterations and reduced quality of life.
There is scientific evidence in the literature to suggest that early postoperative exercise is safe and can improve shoulder function; however, uncertainty remains about the optimal content, timing, and cost-effectiveness of exercise interventions.
The study aims to verify the effectiveness of a rehabilitation treatment in terms of prevention of possible complications following breast cancer surgery.
Primary objective: to examine whether the group of patients undergoing rehabilitation surgery in the immediate post-operative period shows a reduction in the onset of complications compared to the group of patients who followed standard procedures.
Secondary objective: to study any preoperative prognostic factors for the onset of complications, to study the effectiveness of the rehabilitation treatment in terms of reduction of painful symptoms, improvement of joint ROM, muscle strength and perceived quality of life.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Silvia Sterzi, MD
- Phone Number: +390622541624
- Email: s.sterzi@policlinicocampus.it
Study Contact Backup
- Name: Marco Bravi, DPT
- Phone Number: +390622541646
- Email: m.bravi@policlinicocampus.it
Study Locations
-
-
Roma
-
Roma, Roma, Italy, 00128
- Recruiting
- Fondazione Policlinico Universitario Campus Bio-medico
-
Contact:
- Marco Bravi, DPT
- Phone Number: +390622541624
-
Contact:
- Fabio Santacaterina, DPT
- Phone Number: +390622541624
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- diagnosis of breast cancer
- Having undergone quadrantectomy or mastectomy surgery
- Age > 18 years
- Signature of informed consent
Exclusion Criteria:
- Neurological deficits with sensorimotor impairment of the upper limb
- Cognitive deficits that prevent the completion of questionnaires (MMSE>24)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Telerehabilitation
In the days following surgery, intervention group will receive a structured rehabilitation session by a physiotherapist. In this session, two booklets will be provided to the patients, with the aim of informing and educating, regarding the most frequent complications after breast cancer surgery and how to avoid their possible onset through the demonstration of exercises to be carried out at home, self-massage techniques of the scar, behaviors and lifestyle to be adopted immediately after surgery. This group will carry out, starting from 10 days post-surgery, a home tele-rehabilitation intervention from Monday to Friday via the TeleHab device (Vald Performance) until 2 months after surgery. Exercises for ROM recovery and strength recovery will be carried out three days a week and only exercises for ROM recovery will be carried out two days a week. |
The telerehabilitation intervention will begin from 10 days post-surgery, the operation will be carried out at home from Monday to Friday via the TeleHab device (Vald Performance) up to 2 months after the surgery. Exercises for ROM recovery and strength recovery will be carried out three days a week and only exercises for ROM recovery will be carried out two days a week. The progression of the exercises will be carried out taking into account the pain and fatigue recorded by the patient at the end of each exercise session. |
|
Active Comparator: Standard care
Standard care consists of the usual treatment according to current clinical practice, no structured physiotherapeutic interventions will be carried out which generally consists of the delivery of two booklets, with the aim of informing and educating, regarding the most frequent complications after breast cancer surgery and how to avoid its possible onset through the demonstration of exercises to be carried out at home, self-massage techniques for the scar, behaviors and lifestyle to be adopted immediately after surgery.
|
Standard care intervention follow the usual treatment according to current clinical practice, no structured physiotherapeutic interventions will be carried out.
It consists of the delivery of two booklets, with the aim of informing and educating, regarding the most frequent complications after breast cancer surgery and how to avoid its possible onset through the demonstration of exercises to be carried out at home, self-massage techniques for the scar, behaviors and lifestyle to be adopted immediately after surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications
Time Frame: 2 months after surgery
|
Number of complications (i.e.
axyllary web syndrome; lymphedema)
|
2 months after surgery
|
|
Complications
Time Frame: 6 months after surgery
|
Number of complications (i.e.
axyllary web syndrome; lymphedema)
|
6 months after surgery
|
|
Complications
Time Frame: 7-10 days after surgery
|
Number of complications (i.e.
axyllary web syndrome; lymphedema; persistent pain)
|
7-10 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Joint range of motion
Time Frame: before surgery
|
upper limb and cervical range of motion assessed through digital goniometer
|
before surgery
|
|
Joint range of motion
Time Frame: 7-10 days after surgery
|
upper limb and cervical range of motion assessed through digital goniometer
|
7-10 days after surgery
|
|
Joint range of motion
Time Frame: 2 months after surgery
|
upper limb and cervical range of motion assessed through digital goniometer
|
2 months after surgery
|
|
Joint range of motion
Time Frame: 6 months after surgery
|
upper limb and cervical range of motion assessed through digital goniometer
|
6 months after surgery
|
|
Upper limb pain
Time Frame: before surgery
|
Pain assessed through the numeric pain rating scale (0-10)
|
before surgery
|
|
Upper limb pain
Time Frame: 7-10 days after surgery
|
Pain assessed through the numeric pain rating scale (0-10)
|
7-10 days after surgery
|
|
Upper limb pain
Time Frame: 2 months after surgery
|
Pain assessed through the numeric pain rating scale (0-10)
|
2 months after surgery
|
|
Upper limb pain
Time Frame: 6 months after surgery
|
Pain assessed through the numeric pain rating scale (0-10)
|
6 months after surgery
|
|
Neck Disability
Time Frame: before surgery
|
Neck related disability assessed through the questionnaire Neck Disabiltiy Index Value range (0% min disability - 100% max disability)
|
before surgery
|
|
Neck Disability
Time Frame: 7-10 days after surgery
|
Neck related disability assessed through the questionnaire Neck Disability Index Value range (0% min disability - 100% max disability)
|
7-10 days after surgery
|
|
Neck Disability
Time Frame: 2 months after surgery
|
Neck related disability assessed through the questionnaire Neck Disability Index Value range (0% min disability - 100% max disability)
|
2 months after surgery
|
|
Neck Disability
Time Frame: 6 months after surgery
|
Neck related disability assessed through the questionnaire Neck Disability Index Value range (0% min disability - 100% max disability)
|
6 months after surgery
|
|
Upperlimb Disability
Time Frame: before surgery
|
Upperlimb related disability assessed through the questionnaire Disability of the arm, shoulder and hand (DASH) Value range (0% min disability - 100% max disability)
|
before surgery
|
|
Upperlimb Disability
Time Frame: 7-10 days after surgery
|
Upperlimb related disability assessed through the questionnaire Disability of the arm, shoulder and hand (DASH) Value range (0% min disability - 100% max disability)
|
7-10 days after surgery
|
|
Upperlimb Disability
Time Frame: 2 months after surgery
|
Upperlimb related disability assessed through the questionnaire Disability of the arm, shoulder and hand (DASH) Value range (0% min disability - 100% max disability)
|
2 months after surgery
|
|
Upperlimb Disability
Time Frame: 6 months after surgery
|
Upperlimb related disability assessed through the questionnaire Disability of the arm, shoulder and hand (DASH) Value range (0% min disability - 100% max disability)
|
6 months after surgery
|
|
Self-reported Quality of life
Time Frame: before surgery
|
Impact on quality of life assessed through the questionnaire Short Form-36 Health Survey Value range (0 min QoL- 100 max QoL)
|
before surgery
|
|
Self-reported Quality of life
Time Frame: 7-10 days after surgery
|
Impact on quality of life assessed through the questionnaire Short Form-36 Health Survey Value range (0 min QoL- 100 max QoL)
|
7-10 days after surgery
|
|
Self-reported Quality of life
Time Frame: 2 months after surgery
|
Impact on quality of life assessed through the questionnaire Short Form-36 Health Survey Value range (0 min QoL- 100 max QoL)
|
2 months after surgery
|
|
Self-reported Quality of life
Time Frame: 6 months after surgery
|
Impact on quality of life assessed through the questionnaire Short Form-36 Health Survey Value range (0 min QoL- 100 max QoL)
|
6 months after surgery
|
|
Muscle strength
Time Frame: before surgery
|
handgrip, shoulder and neck muscle strength assessed through handheld dynamometer
|
before surgery
|
|
Muscle strength
Time Frame: 7-10 days after surgery
|
handgrip, shoulder and neck muscle strength assessed through handheld dynamometer
|
7-10 days after surgery
|
|
Muscle strength
Time Frame: 2 months after surgery
|
handgrip, shoulder and neck muscle strength assessed through handheld dynamometer
|
2 months after surgery
|
|
Muscle strength
Time Frame: 6 months after surgery
|
handgrip, shoulder and neck muscle strength assessed through handheld dynamometer
|
6 months after surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms by Site
- Neoplasms
- Skin Diseases
- Breast Diseases
- Skin and Connective Tissue Diseases
- Breast Neoplasms
- Health Services Administration
- Delivery of Health Care
- Health Care Quality, Access, and Evaluation
- Therapeutics
- Quality of Health Care
- Quality Indicators, Health Care
- Patient Care
- Health Services
- Health Care Facilities Workforce and Services
- Rehabilitation
- Aftercare
- Continuity of Patient Care
- Telemedicine
- Patient Care Management
- Standard of Care
- Telerehabilitation
Other Study ID Numbers
- 2023.032
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Neoplasms
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Dana-Farber Cancer InstituteIncyte CorporationActive, not recruitingInflammatory Breast Cancer (IBC)United States
-
Providence Health & ServicesBrooklyn ImmunoTherapeutics, LLCCompletedBreast Neoplasm | Triple Negative Breast Cancer | Breast Neoplasm, MaleUnited States
-
Xijing HospitalActive, not recruitingBreast Cancer | Breast Cancer (Triple Negative Breast Cancer (TNBC))China
-
BerGenBio ASAMerck Sharp & Dohme LLCTerminatedTriple Negative Breast Cancer | Inflammatory Breast Cancer Stage IVSpain, United States, United Kingdom, Norway
-
CytomX TherapeuticsCompletedNeoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 NegativeUnited States, Spain, Korea, Republic of
-
Emory UniversityEisai Inc.TerminatedBreast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Tumors, BreastUnited States
-
Emory UniversityCompletedBreast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of Breast | Cancer of the Breast | Human Mammary CarcinomaUnited States
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
Clinical Trials on Telerehabilitation
-
University of SalernoAzienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'AragonaRecruiting
-
Saglik Bilimleri UniversitesiCompletedQuality of Life | Fatigue | Muscle Weakness | Pulmonary Disease | COPD | Respiratory Disease | Dyspnea | Muscle Strength | Functional Capacity | Severe Chronic Obstructive Pulmonary Disease | Motor Imagery | Muscle; AccessoryTurkey
-
Biruni UniversityNot yet recruitingPremature Birth of Newborn | Motor Delay | Risky BabyTurkey (Türkiye)
-
Marmara UniversityCompletedHemiparetic Cerebral PalsyTurkey
-
Bright Cloud International CorpNational Cancer Institute (NCI); Rutgers, The State University of New JerseyRecruitingCognitive Impairment, MildUnited States
-
University of Eastern FinlandOulu University Hospital; Kuopio University HospitalRecruiting
-
Sakarya Applied Sciences UniversityNot yet recruitingMusculoskeletal Diseases | Postural; Defect | DriveTurkey
-
King Saud UniversityRecruitingKnee OsteoarthritisSaudi Arabia
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCoronavirus Infections | Quality of Life | Covid19 | Respiratory Failure | ARDS | Dyspnea | Respiratory Rehabilitation | Sars-CoV-2 | Interstitial PneumoniaItaly
-
SOS Oxygene MediterraneeRecruitingExercise | Chronic Respiratory DiseaseFrance